1. Chanson P, Salenave S. Metabolic syndrome in Cushing's syndrome. Neuroendocrinology. 2010; 92(Suppl 1):96–101. PMID:
20829627.
Article
2. Di Somma C, Pivonello R, Loche S, Faggiano A, Marzullo P, Di Sarno A, et al. Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease. Clin Endocrinol (Oxf). 2002; 56:153–158. PMID:
11874405.
Article
3. Pivonello R, De Leo M, Vitale P, Cozzolino A, Simeoli C, De Martino MC, et al. Pathophysiology of diabetes mellitus in Cushing's syndrome. Neuroendocrinology. 2010; 92(Suppl 1):77–81. PMID:
20829623.
Article
4. Vegiopoulos A, Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol. 2007; 275:43–61. PMID:
17624658.
Article
5. Mazziotti G, Gazzaruso C, Giustina A. Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol Metab. 2011; 22:499–506. PMID:
21993190.
Article
6. Bakker RC, Gallas PR, Romijn JA, Wiersinga WM. Cushing's syndrome complicated by multiple opportunistic infections. J Endocrinol Invest. 1998; 21:329–333. PMID:
9648056.
Article
7. Bronsart LL, Contag CH. A role of the adaptive immune system in glucose homeostasis. BMJ Open Diabetes Res Care. 2016; 4:e000136.
Article
8. Lackey DE, Olefsky JM. Regulation of metabolism by the innate immune system. Nat Rev Endocrinol. 2016; 12:15–28. PMID:
26553134.
Article
9. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science. 2011; 332:243–247. PMID:
21436399.
Article
10. Zhu L, Su T, Xu M, Xu Y, Li M, Wang T, et al. Eosinophil inversely associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS One. 2013; 8:e67613. PMID:
23894289.
Article
11. Ambrogio AG, De Martin M, Ascoli P, Cavagnini F, Pecori Giraldi F. Gender-dependent changes in haematological parameters in patients with Cushing’s disease before and after remission. Eur J Endocrinol. 2014; 170:393–400. PMID:
24362410.
Article
12. Greenblatt RB. Vagaries in the symptomatology of Cushing's syndrome. J Clin Endocrinol Metab. 1954; 14:961–968. PMID:
13183989.
Article
13. Kronfol Z, Starkman M, Schteingart DE, Singh V, Zhang Q, Hill E. Immune regulation in Cushing's syndrome: relationship to hypothalamic-pituitary-adrenal axis hormones. Psychoneuroendocrinology. 1996; 21:599–608. PMID:
9044443.
Article
14. Brode S, Farahi N, Cowburn AS, Juss JK, Condliffe AM, Chilvers ER. Interleukin-5 inhibits glucocorticoid-mediated apoptosis in human eosinophils. Thorax. 2010; 65:1116–1117. PMID:
20805156.
Article
15. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol. 1991; 147:3490–3495. PMID:
1940348.
16. Altman LC, Hill JS, Hairfield WM, Mullarkey MF. Effects of corticosteroids on eosinophil chemotaxis and adherence. J Clin Invest. 1981; 67:28–36. PMID:
7005265.
Article
17. Hallsworth MP, Litchfield TM, Lee TH. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology. 1992; 75:382–385. PMID:
1551701.
18. Geley S, Hartmann BL, Kapelari K, Egle A, Villunger A, Heidacher D, et al. The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells. FEBS Lett. 1997; 402:36–40. PMID:
9013854.
19. Miyashita T, Mami U, Inoue T, Reed JC, Yamada M. Bcl-2 relieves the trans-repressive function of the glucocorticoid receptor and inhibits the activation of CPP32-like cysteine proteases. Biochem Biophys Res Commun. 1997; 233:781–787. PMID:
9168933.
Article
20. Suzukawa M, Koketsu R, Iikura M, Nakae S, Matsumoto K, Nagase H, et al. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest. 2008; 88:1245–1253. PMID:
18762778.
Article
21. Cildir G, Akincilar SC, Tergaonkar V. Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol Med. 2013; 19:487–500. PMID:
23746697.
Article
22. Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014; 222:R113–R127. PMID:
25006217.
Article
23. Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI, Jouihan H, Morel CR, Heredia JE, et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci U S A. 2010; 107:22617–22622. PMID:
21149710.
Article
24. Stanya KJ, Jacobi D, Liu S, Bhargava P, Dai L, Gangl MR, et al. Direct control of hepatic glucose production by interleukin-13 in mice. J Clin Invest. 2013; 123:261–271. PMID:
23257358.
Article
25. Nittoh T, Fujimori H, Kozumi Y, Ishihara K, Mue S, Ohuchi K. Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats. Eur J Pharmacol. 1998; 354:73–81. PMID:
9726633.
Article
26. Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB, et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature. 2013; 502:245–248. PMID:
24037376.
Article